Not Routinely Funded
Based on the evidence of clinical and cost effectiveness provided in this document, Toric Intraocular Lenses (IOL) for astigmatism correction in patients undergoing cataract surgery will not be routinely funded. This is due to a lack of quality evidence regarding the long term clinical effectiveness of this procedure. There is some evidence to support a case for clinical effectiveness yet the overall quantity of that evidence is such that there is too great a measure of uncertainty over whether the claims made for treatment can be justified.
IFR Form required to be completed.
||27 October 2015
|Next Review date